MAIA Biotechnology, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Subsequent Events - Additional Information - (Details)

Subsequent Events - Additional Information - (Details) - USD ($)					1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended
	Mar. 18, 2024	Mar. 11, 2024	Feb. 14, 2024	Aug. 03, 2022	May 31, 2022	Feb. 28, 2022	Mar. 21, 2024	Dec. 31, 2023	Dec. 31, 2022	Aug. 01, 2022
Subsequent Event [Line Items]
Options outstanding, Granted								1,607,027
Weighted average Exercise Price, Exercised								$ 1.91
Common stock per share						$ 9
Gross proceeds from sale of common stock				$ 9,100,000	$ 99,999	$ 2,373,561			$ 2,473,560
Warrants exercise price, per share										$ 6.25
Common stock, par value								$ 0.0001	$ 0.0001
Stan Smith \| Private Placement
Subsequent Event [Line Items]
Number of common stock sold								170,940
Warrants to purchase common stock								170,940
Aggregate purchase price								$ 200,000
Louie Ngar Yee \| Private Placement
Subsequent Event [Line Items]
Number of common stock sold								170,940
Warrants to purchase common stock								170,940
Aggregate purchase price								$ 200,000
Cristian Luput \| Private Placement
Subsequent Event [Line Items]
Number of common stock sold								69,282
Warrants to purchase common stock								69,282
Aggregate purchase price								$ 81,060
Steven Chaouki \| Private Placement
Subsequent Event [Line Items]
Number of common stock sold								34,641
Warrants to purchase common stock								34,641
Aggregate purchase price								$ 40,530
Ramiro Guerrero \| Private Placement
Subsequent Event [Line Items]
Number of common stock sold								6,928
Warrants to purchase common stock								6,928
Aggregate purchase price								$ 8,106
Common Stock
Subsequent Event [Line Items]
Number of common stock sold					11,111	263,729
Subsequent Event
Subsequent Event [Line Items]
Options outstanding, Granted							456,545
Weighted average Exercise Price, Exercised							$ 1.41
Subsequent Event \| At The Market Offering Agreement \| H.C. Wainwright and Co., LLC
Subsequent Event [Line Items]
Number of common stock sold			507,754
Common stock per share			$ 1.47
Gross proceeds from sale of common stock			$ 745,250
Common stock, par value			$ 0.0001
Percentage of gross proceeds of offerings			3.00%
Subsequent Event \| Private Placement
Subsequent Event [Line Items]
Number of common stock sold		452,731
Gross proceeds from sale of common stock		$ 2,920,000
Warrants exercise price, per share		$ 1.3
Subsequent Event \| Common Stock
Subsequent Event [Line Items]
Shares issued for services	12,500
Subsequent Event \| Common Stock \| Private Placement
Subsequent Event [Line Items]
Number of common stock sold		2,043,587
Warrants exercise price, per share		$ 1.3
Common stock, par value		$ 0.0001
Subsequent Event \| Common Stock \| Maximum \| At The Market Offering Agreement \| H.C. Wainwright and Co., LLC
Subsequent Event [Line Items]
Aggregate sales price			$ 1,445,000
Subsequent Event \| Warrants \| Private Placement
Subsequent Event [Line Items]
Number of common stock sold		452,731
Common stock per share		$ 1.17
Aggregate purchase price		$ 529,695
Subsequent Event \| Investor Warrants \| Private Placement
Subsequent Event [Line Items]
Number of common stock sold		2,043,587
Common stock per share		$ 1.17
Aggregate purchase price		$ 2,400,000